Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative crossover trial of rotigotine transdermal patches in Parkinson's disease
2021-000867-65Phase 2Completed
- Sponsor
- Luye Pharma Group
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of rotigotine in Parkinson's disease (PD) (2 arms), sponsored by Luye Pharma Group. Primary endpoint: Patch adhesion at the end of the dosing interval. Started Mar 2021; status: completed.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2021-000867-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000867-65.